Clinical trial Recruiting at 1 site Interventional Ages 40 to 85

Using music to reduce apathy in Parkinson's Disease

Official title: The Role of a Personalized Music Intervention Towards Alleviating Apathy in Parkinson's Disease

Run by University of British Columbia · NCT05505019 · Data updated 2026-11-12

This study tests whether listening to music can help reduce feelings of apathy in people with Parkinson's Disease.

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity of British Columbia
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedFebruary 9, 2022
Main results expectedJuly 31, 2026
Study endsJuly 31, 2026
Registry record updatedMarch 23, 2026
Trial IDNCT05505019 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with Parkinson's Disease who experience symptoms of apathy.

Probably not a fit

Patients with atypical Parkinsonism, significant cognitive impairment, or other neurological complications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of music listening on apathy in patients with Parkinson's Disease (PD), a common non-motor symptom that significantly impacts quality of life. Apathy is characterized by a lack of motivation and emotional engagement, and current treatments have been largely ineffective. The research aims to explore how music can influence brain mechanisms associated with motivation and reward-seeking behaviors in PD patients. Participants will engage in music and podcast listening interventions to assess changes in apathy levels and overall functioning.

Why it matters

Potential benefit: If successful, this approach could provide a non-pharmacological intervention to alleviate apathy in Parkinson's Disease patients, improving their quality of life.

How similar studies have gone: Previous studies have shown positive effects of music-based interventions in older adults, suggesting potential for success in this novel application for Parkinson's Disease.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- Clinical diagnosis of Parkinson's Disease following MDS Parkinson's disease criteria

Exclusion Criteria:

* Participants with atypical Parkinsonism (eg. Progressive supranuclear palsy, multiple system atrophy, drug induced, etc.)
* Epilepsy
* Other neurological disease/complications (eg. myopathy, stroke, brain lesion, MS)
* Significant cognitive impairment (MoCa \<21)
* Moderate depression (Beck's Depression Inventory \>20)
* Severe/multiple head trauma(s)
* Participants with metal/medical implants, including any of the following: artificial heart valve, brain aneurysm clip, electrical stimulators, ear or eye implant, implanted drug infusion pump, coil, catheter, or filter in any blood vessel, orthopedic hardware such as artificial joint, plate, and/or screws, other metallic prostheses, shrapnel, bullets, or other metal fragments, surgery or tattoos, including tattooed eyeliner, in the last six weeks, cardiac pacemaker, wires or defibrillator, or ferromagnetic aneurysm clip)
* Participants who have gone through specific injuries/brain surgery (eg. an injury where a piece of metal lodged in the eye or orbit)

Where it's running

  • Djavad Mowafghian Centre for Brain Health
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.